Clinical Trial: A Study to Access Activity and Safety With SAR445399 Compared With Placebo in Participants Aged 18 to 80 Years of Age With Non-Cystic Fibrosis Bronchiectasis

U.S., April 24 -- ClinicalTrials.gov registry received information related to the study (NCT07547436) titled 'A Study to Access Activity and Safety With SAR445399 Compared With Placebo in Participants Aged 18 to 80 Years of Age With Non-Cystic Fibrosis Bronchiectasis' on April 17.

Brief Summary: This is a randomized, double-blind, placebo-controlled study to measure the reduction in mucus plug score at 24 weeks of treatment with SAR445399 compared with placebo in adult participants aged 18 to 80 years with non-cystic fibrosis bronchiectasis (NCFB).

Study Start Date: April 13

Study Type: INTERVENTIONAL

Condition: Non-cystic Fibrosis Bronchiectasis

Intervention: BIOLOGICAL: SAR445399

Pharmaceutical form:

solution for injection

Route...